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The TSPAN1 gene is located on chromosome 1 in a 
5419 bp sequence (46418799..46424217). The gene 
contains 10 exons. 
Transcription 
mRNA: 1297 nucleotides in length. 
Protein 
Description 
241 amino acids, 26.2 kDa protein. 
The 241 amino acid sequence is:  
1 mqcfsfiktm milfnllifl cgaallavgi wvsidgasfl kifgplsssa 
mqfvnvgyfl;  
61 iaagvvvfal gflgcygakt eskcalvtff filllifiae vaaavvalvy 
ttmaehfltl;  
121 lvvpaikkdy gsqedftqvw nttmkglkcc gftnytdfed spyfkensaf 
ppfccndnvt;  








The protein encoded by this gene is a member of the 
transmembrane 4 superfamily, also known as the 
tetraspanin family. These are cell-surface proteins that 
are characterized by the presence of four hydrophobic 
domains. The proteins mediate signal transduction 
events that play a role in the regulation of cell 
development, activation, growth and motility. 
Homology 
Holomogy with Pan troglodytes (100%); Canis lupus 
familiaris (89%); Mus musculus (82%), Rattus 
norvegicus (82%), Gallus gallus (70%). 
Mutations 
Note: TSPAN1 is subject to the following misense 
mutations :  
 
Source ID rs2234266 rs2234267 rs2234268 rs1047216 
Wild type 
nucleotide 
A C G A 
Wild type 
amino acid 
M S V K 
Variant 
nucleotide 
G T A G 
Variant 
amino acid 








Cervical cancer is a malignant carcinoma or the cervix, 
typically composed of squamous cells. Most studies 
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have found that human papillomavirus (HPV) infection 
is responsible for virtually all cases of cervical cancer. 
Prognosis 
Prognosis depends on the stage of the cancer. The 5 
year survival rate with treatment is 80 to 90% in 
patients with stage I disease and 50 to 65% in patients 
with stage II disease. 25 to 35% of women with stage 
III cancer and 15% or fewer of those with stage IV 
cancer are alive after 5 years. Prognosis drops 
dramatically with tumour metastasis. Thirty-five 
percent of patients with invasive cervical cancer have 
persistent or recurrent disease after treatment. 
Hepatocellular carcinoma 
Disease 
Hepatocellular carcinoma (HCC) is a malignancy of the 
liver. Most cases of HCC are secondary to either a 





The prognosis of HCC is dependent on many factors, 
including tumour size, tumour staging, the involvement 
of liver vessels, the presence of extrahepatic metastases 
and the vascularisation of the tumor. 
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